| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A tobacco-free generation: the end goal of the endgame
|
The Lancet Respiratory Medicine,
|
|
|
12 |
3 |
p. 181
|
article
|
| 2 |
Australia to ban disposable vapes in 2024
|
Kirby, Tony
|
|
|
12 |
3 |
p. e12
|
article
|
| 3 |
Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis
|
Zampieri, Fernando G
|
|
|
12 |
3 |
p. 237-246
|
article
|
| 4 |
Coal power plant pollution linked to deaths in the USA
|
Furlow, Bryant
|
|
|
12 |
3 |
p. 193
|
article
|
| 5 |
Individualised, perioperative open-lung ventilation strategy during one-lung ventilation (iPROVE-OLV): a multicentre, randomised, controlled clinical trial
|
Ferrando, Carlos
|
|
|
12 |
3 |
p. 195-206
|
article
|
| 6 |
Individualised perioperative ventilation in one-lung anaesthesia?
|
Buggy, Pádraig M
|
|
|
12 |
3 |
p. 182-183
|
article
|
| 7 |
Interpreting posterior probabilities in Bayesian analyses of clinical trials
|
Yarnell, Christopher J
|
|
|
12 |
3 |
p. 188-190
|
article
|
| 8 |
Normal saline versus balanced crystalloids: is it all about sodium?
|
Messmer, Anna S
|
|
|
12 |
3 |
p. 187-188
|
article
|
| 9 |
Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis
|
Gioia, Francesca
|
|
|
12 |
3 |
p. 207-216
|
article
|
| 10 |
Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?
|
Hoenigl, Martin
|
|
|
12 |
3 |
p. 183-185
|
article
|
| 11 |
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens
|
White, R James
|
|
|
12 |
3 |
p. e9-e10
|
article
|
| 12 |
Risk scores as a surrogate in pulmonary arterial hypertension: a different lens – Authors' reply
|
Harhay, Michael O
|
|
|
12 |
3 |
p. e11
|
article
|
| 13 |
Shaping urban environments to improve respiratory health: recommendations for research, planning, and policy
|
Nieuwenhuijsen, Mark
|
|
|
12 |
3 |
p. 247-254
|
article
|
| 14 |
Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6): single-arm, open-label, multicentre, phase 2 trial
|
Wang, Mengzhao
|
|
|
12 |
3 |
p. 217-224
|
article
|
| 15 |
Sunvozertinib: the next candidate of TKI for NSCLC
|
Hayashi, Hidetoshi
|
|
|
12 |
3 |
p. 185-186
|
article
|
| 16 |
The effectiveness of COVID-19 vaccines to prevent long COVID symptoms: staggered cohort study of data from the UK, Spain, and Estonia
|
Català, Martí
|
|
|
12 |
3 |
p. 225-236
|
article
|
| 17 |
The lung is not a balloon: the self-sealing property of the lung
|
Chopra, Amit
|
|
|
12 |
3 |
p. 190-192
|
article
|
| 18 |
Tobacco Slave: Imperial Practices in the Modern Age
|
Burki, Talha
|
|
|
12 |
3 |
p. 194
|
article
|
| 19 |
What is next for BCG revaccination to prevent tuberculosis?
|
White, Richard G
|
|
|
12 |
3 |
p. e7-e8
|
article
|
Journal description